Offer - Urjas Oil for just ₹ 1 X
Valzaar H 40 Tablet (10) is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Valzaar H 40 Tablet (10) have also been mentioned below.
The optimal dosage of Valzaar H 40 Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Valzaar H 40 Tablet (10) can also lead to other problems, which have been listed below. Usually, these side effects of Valzaar H 40 Tablet (10) go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
In addition, Valzaar H 40 Tablet (10)'s effect is Safe during pregnancy and Safe for lactating mothers. It is important to know if Valzaar H 40 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Valzaar H 40 Tablet (10) related warnings section.
Valzaar H 40 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Valzaar H 40 Tablet (10) in conditions like Bradycardia (Slow Heart Rate), Allergy, Hyperkalemia. Some other conditions that can be affected by Valzaar H 40 Tablet (10) are listed in the contraindications section below.
Drug reaction of Valzaar H 40 Tablet (10) with other medicines has been reported. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Valzaar H 40 Tablet (10) is considered not safe while driving, and is not addictive.
Valzaar H 40 Tablet (10) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Valzaar H 40 Tablet (10) safe for pregnant women?
Pregnant women can take Valzaar H without worrying about any side effects.
Is the use of Valzaar H 40 Tablet (10) safe during breastfeeding?
Breastfeeding women can safely use Valzaar H.
What is the effect of Valzaar H 40 Tablet (10) on the Kidneys?
Valzaar H may have mild side effects on the kidneys.
What is the effect of Valzaar H 40 Tablet (10) on the Liver?
Valzaar H is rarely harmful for the liver.
What is the effect of Valzaar H 40 Tablet (10) on the Heart?
Valzaar H may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Valzaar H 40 Tablet (10) unless your doctor advises you to do so -
Is this Valzaar H 40 Tablet (10) habit forming or addictive?
Valzaar H 40 Tablet (10) is not addictive in nature.
Interaction between Food and Valzaar H 40 Tablet (10)
Valzaar H 40 Tablet (10) may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Valzaar H 40 Tablet (10)
Consult your doctor before consuming alcohol while taking Valzaar H 40 Tablet (10) as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-172
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diovan (valsartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prexxartan (valsartan)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448